Trials / Conditions / Laryngeal Squamous Cell Carcinoma

Laryngeal Squamous Cell Carcinoma

18 registered clinical trials studyying Laryngeal Squamous Cell Carcinoma — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN281 NCT06980038	National Cancer Institute (NCI)	Phase 2
Not Yet Recruiting	Intralesional Chemotherapy (IC): Cisplatin + Epinephrine NCT07392580	University of Miami	Phase 2
Not Yet Recruiting	Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer NCT07058805	Olgun Elicin	Phase 2
Recruiting	Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin a NCT06662058	Emory University	N/A
Recruiting	Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy f NCT06532279	NRG Oncology	Phase 2
Recruiting	Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluati NCT06914999	Emory University	EARLY_Phase 1
Recruiting	Decisional Regret in Open Partial Horizontal Laryngectomy NCT06805071	IRCCS Azienda Ospedaliero-Universitaria di Bologna	—
Recruiting	European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] NCT06137378	University of Leipzig	Phase 2
Withdrawn	Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carbopl NCT06084845	ECOG-ACRIN Cancer Research Group	Phase 2
Recruiting	Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The NCT05333523	Radboud University Medical Center	Phase 3
Terminated	A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and NCT05551117	MacroGenics	Phase 2
Unknown	Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous NCT05832593	Assiut University	—
Unknown	IMP3 and PCNA Expression in Laryngeal Squamous Cell Carcinoma in Sohag Governorate NCT05293327	Sohag University	—
Active Not Recruiting	Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer NCT04030455	M.D. Anderson Cancer Center	Phase 2
Completed	Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck NCT03258554	National Cancer Institute (NCI)	Phase 2 / Phase 3
Recruiting	Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of NCT02734537	ECOG-ACRIN Cancer Research Group	Phase 2
Terminated	Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck NCT02582008	Wake Forest University Health Sciences	EARLY_Phase 1
Completed	A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck Cancer NCT01314755	Terrence Jones	N/A